Gene expression of forkhead transcription factors in the normal and diseased human prostate
- PMID: 19220249
- DOI: 10.1111/j.1464-410X.2009.08351.x
Gene expression of forkhead transcription factors in the normal and diseased human prostate
Abstract
OBJECTIVE To assess the expression of forkhead transcription factors (FOX) in normal prostate and prostate diseases, as since the first FOX was identified, its family members have been implicated in a variety of cellular processes, including embryonic development and disease. MATERIAL AND METHODS We analysed a set of 12 different FOX genes by quantitative reverse transcription-polymerase chain reaction in prostate zones, prostate cancer, lymph node metastases, benign prostatic hyperplasia (BPH), xenografts and several prostate cell lines. RESULTS There were striking differences among the expression of various FOX family members; most prominent were the high expression of FOXF1 and FOXF2 in the normal prostate transition zone and BPH, and their decreased expression in prostate cancer. Interestingly, although the FOXF genes are stroma-specific, some of the androgen-independent prostate cancer xenografts uniquely express these two genes. FOXD1 and FOXD2 were more highly expressed in prostate cancer and lymph node metastases. FOXA1 and FOXC1 have an opposite expression pattern for androgen-dependent growth of prostate cancer cell lines and xenografts. CONCLUSIONS Various members of the FOX family are differentially expressed in the zones of the normal prostate and in benign and malignant outgrowths. The expression profiles of FOXF1 and FOXF2 suggest a role in epithelial to mesenchymal transition, while FOXA1 and FOXC1 expression is linked to androgen-associated growth status of cancer.
Similar articles
-
Update of human and mouse forkhead box (FOX) gene families.Hum Genomics. 2010 Jun;4(5):345-52. doi: 10.1186/1479-7364-4-5-345. Hum Genomics. 2010. PMID: 20650821 Free PMC article. Review.
-
Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.PLoS One. 2009 Dec 21;4(12):e8384. doi: 10.1371/journal.pone.0008384. PLoS One. 2009. PMID: 20027305 Free PMC article.
-
Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.J Cell Physiol. 2007 Jan;210(1):111-21. doi: 10.1002/jcp.20828. J Cell Physiol. 2007. PMID: 17044071 Free PMC article.
-
Human FOX gene family (Review).Int J Oncol. 2004 Nov;25(5):1495-500. Int J Oncol. 2004. PMID: 15492844 Review.
-
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.Clin Cancer Res. 1997 May;3(5):805-15. Clin Cancer Res. 1997. PMID: 9815753
Cited by
-
Exploration of diagnostic biomarkers, microenvironment characteristics, and ursolic acid's therapeutic effect for benign prostate hyperplasia.Int J Biol Sci. 2023 Aug 15;19(13):4242-4258. doi: 10.7150/ijbs.85739. eCollection 2023. Int J Biol Sci. 2023. PMID: 37705744 Free PMC article.
-
The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma.J Pers Med. 2023 Mar 15;13(3):530. doi: 10.3390/jpm13030530. J Pers Med. 2023. PMID: 36983712 Free PMC article.
-
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.Nat Commun. 2022 Nov 11;13(1):6828. doi: 10.1038/s41467-022-34665-z. Nat Commun. 2022. PMID: 36369237 Free PMC article.
-
USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1.Cell Death Dis. 2022 Aug 16;13(8):712. doi: 10.1038/s41419-022-05163-3. Cell Death Dis. 2022. PMID: 35974001 Free PMC article.
-
FOXF2 Regulates PRUNE2 Transcription in the Pathogenesis of Colorectal Cancer.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221118717. doi: 10.1177/15330338221118717. Technol Cancer Res Treat. 2022. PMID: 35929169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases